Literature DB >> 29770052

Surveillance of laboratory exposures to human pathogens and toxins: Canada 2016.

A Bienek1, M Heisz1, M Su1.   

Abstract

BACKGROUND: Canada recently enacted legislation to authorize the collection of data on laboratory incidents involving a biological agent. This is done by the Public Health Agency of Canada (PHAC) as part of a comprehensive national program that protects Canadians from the health and safety risks posed by human and terrestrial animal pathogens and toxins.
OBJECTIVE: To describe the first year of data on laboratory exposure incidents and/or laboratory-acquired infections in Canada since the Human Pathogens and Toxins Regulations came into effect.
METHODS: Incidents that occurred between January 1 and December 31, 2016 were self-reported by federally-regulated parties across Canada using a standardized form from the Laboratory Incident Notification Canada (LINC) surveillance system. Exposure incidents were described by sector, frequency of occurrence, timeliness of reporting, number of affected persons, human pathogens and toxins involved, causes and corrective actions taken. Microsoft Excel 2010 was used for basic descriptive analyses.
RESULTS: In 2016, 46 exposure incidents were reported by holders of 835 active licences in Canada representing 1,352 physical areas approved for work involving a biological agent, for an overall incidence of 3.4%. The number of incidents was highest in the academic (n=16; 34.8%) and hospital (n=12; 26.1%) sectors, while the number of reported incidents was relatively low in the private industry sector. An average of four to five incidents occurred each month; the month of September presented as an outlier with 10 incidents.​: A total of 100 people were exposed, with no reports of secondary exposure. Four incidents led to suspected (n=3) or confirmed (n=1) cases of laboratory-acquired infection. Most incidents involved pathogens classified at a risk group 2 level that were manipulated in a containment level 2 laboratory (91.3%). Over 22 different species of human pathogens and toxins were implicated, with bacteria the most frequent (34.8%), followed by viruses (26.1%). Eleven (23.9%) incidents involved a security sensitive biologic agent. Procedure breaches (n=15) and sharps-related incidents (n=14) were the most common antecedents to an exposure. In 10 (21.7%) cases, inadvertent possession (i.e., isolation of an unexpected biological agent during routine work) played a role. Possible improvements to standard operating procedures were cited in 71.7% of incidents. Improvements were also indicated for communication (26.1%) and management (23.9%).
CONCLUSIONS: The Laboratory Incident Notification Canada is one of the first surveillance systems in the world to gather comprehensive data on laboratory incidents involving human pathogens and toxins. Exposure incidents reported in the first year were relatively rare, occurring in less than 4% of containment zones within laboratory settings.

Entities:  

Year:  2017        PMID: 29770052      PMCID: PMC5764741          DOI: 10.14745/ccdr.v43i11a04

Source DB:  PubMed          Journal:  Can Commun Dis Rep        ISSN: 1188-4169


  14 in total

1.  Bacterial and fungal infections among diagnostic laboratory workers: evaluating the risks.

Authors:  Ellen Jo Baron; J Michael Miller
Journal:  Diagn Microbiol Infect Dis       Date:  2007-11-08       Impact factor: 2.803

2.  Compliance with personal precautions against exposure to bloodborne pathogens among laboratory workers: a Canadian survey .

Authors:  Cheryl L Main; Soo Chan Carusone; Kurt Davis; Mark Loeb
Journal:  Infect Control Hosp Epidemiol       Date:  2008-01       Impact factor: 3.254

3.  Brucellae growing on Thayer-Martin medium: a source of inadvertent exposure for laboratory personnel in endemic areas.

Authors:  Pablo Yagupsky
Journal:  J Med Microbiol       Date:  2013-09-26       Impact factor: 2.472

4.  Laboratory-associated infections: summary and analysis of 3921 cases.

Authors:  R M Pike
Journal:  Health Lab Sci       Date:  1976-04

5.  Fatal laboratory-acquired infection with an attenuated Yersinia pestis Strain--Chicago, Illinois, 2009.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-02-25       Impact factor: 17.586

6.  Smallpox death in Britain challenges presumption of laboratory safety.

Authors:  N Hawkes
Journal:  Science       Date:  1979-03-02       Impact factor: 47.728

Review 7.  A literature review of laboratory-acquired brucellosis.

Authors:  Rita M Traxler; Mark W Lehman; Elizabeth A Bosserman; Marta A Guerra; Theresa L Smith
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

8.  Regulatory oversight of human pathogens and toxins in Canada.

Authors:  C Labrie; S Lecordier
Journal:  Can Commun Dis Rep       Date:  2015-12-17

9.  Seroprevalence of hepatitis B virus infection and hepatitis B surface antibody status among laboratory health care workers in Isfahan, Iran.

Authors:  Parisa Shoaei; Somayeh Najafi; Noushin Lotfi; Bahareh Vakili; Behrooz Ataei; Majid Yaran; Rezvan Shafiei
Journal:  Asian J Transfus Sci       Date:  2015 Jul-Dec

Review 10.  The importance of implementing safe sharps practices in the laboratory setting in Europe.

Authors:  Gabriella De Carli; Dominique Abiteboul; Vincenzo Puro
Journal:  Biochem Med (Zagreb)       Date:  2014-02-15       Impact factor: 2.313

View more
  5 in total

1.  Surveillance of laboratory exposures to human pathogens and toxins, Canada 2020.

Authors:  Nicole Atchessi; Megan Striha; Rojiemiahd Edjoc; Emily Thompson; Maryem El Jaouhari; Marianne Heisz
Journal:  Can Commun Dis Rep       Date:  2021-10-14

2.  Surveillance of laboratory exposures to human pathogens and toxins: Canada 2017.

Authors:  D Pomerleau-Normandin; M Heisz; F Tanguay
Journal:  Can Commun Dis Rep       Date:  2018-11-01

3.  Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.

Authors:  D Choucrallah; L Sarmiento; S Ettles; F Tanguay; M Heisz; E Falardeau
Journal:  Can Commun Dis Rep       Date:  2019-09-05

4.  Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.

Authors:  Sandra Appelt; Daniela Jacob; Anna-Maria Rohleder; Andreas Bråve; Åsa Szekely Björndal; Antonino Di Caro; Roland Grunow
Journal:  Euro Surveill       Date:  2020-09

Review 5.  Zika Virus Infection During Research Vaccine Development: Investigation of the Laboratory-Acquired Infection via Nanopore Whole-Genome Sequencing.

Authors:  Eunsik Bang; Sujin Oh; Ho Eun Chang; Il Seob Shin; Kyoung Un Park; Eu Suk Kim
Journal:  Front Cell Infect Microbiol       Date:  2022-03-07       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.